BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 8923073)

  • 1. Influence of different volume therapies on platelet function in the critically ill.
    Boldt J; Müller M; Heesen M; Heyn O; Hempelmann G
    Intensive Care Med; 1996 Oct; 22(10):1075-81. PubMed ID: 8923073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Volume therapy in the critically ill: is there a difference?
    Boldt J; Müller M; Mentges D; Papsdorf M; Hempelmann G
    Intensive Care Med; 1998 Jan; 24(1):28-36. PubMed ID: 9503219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does the type of volume therapy influence endothelial-related coagulation in the critically ill?
    Boldt J; Heesen M; Welters I; Padberg W; Martin K; Hempelmann G
    Br J Anaesth; 1995 Dec; 75(6):740-6. PubMed ID: 8672323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of albumin versus hydroxyethyl starch solution on cardiorespiratory and circulatory variables in critically ill patients.
    Boldt J; Heesen M; Müller M; Pabsdorf M; Hempelmann G
    Anesth Analg; 1996 Aug; 83(2):254-61. PubMed ID: 8694302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does long-term continuous administration of pentoxifylline affect platelet function in the critically ill patient?
    Boldt J; Müller M; Heesen M; Heyn S; Hempelmann G
    Intensive Care Med; 1996 Jul; 22(7):644-50. PubMed ID: 8844228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of different volume therapy regimens on regulators of the circulation in the critically ill.
    Boldt J; Mueller M; Menges T; Papsdorf M; Hempelmann G
    Br J Anaesth; 1996 Oct; 77(4):480-7. PubMed ID: 8942332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does continuous heparinization influence platelet function in the intensive care patient?
    Boldt J; Müller M; Rothe A; Lenzen P; Hempelmann G
    Intensive Care Med; 1997 May; 23(5):567-73. PubMed ID: 9201530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxyethyl starch for fluid resuscitation in critically ill patients.
    Bagshaw SM; Chawla LS
    Can J Anaesth; 2013 Jul; 60(7):709-13. PubMed ID: 23604905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of different intravascular volume therapies on platelet function in patients undergoing cardiopulmonary bypass.
    Boldt J; Knothe C; Zickmann B; Andres P; Dapper F; Hempelmann G
    Anesth Analg; 1993 Jun; 76(6):1185-90. PubMed ID: 7684579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large-dose administration of 6% hydroxyethyl starch 200/0.5 total hip arthroplasty: plasma homeostasis, hemostasis, and renal function compared to use of 5% human albumin.
    Vogt NH; Bothner U; Lerch G; Lindner KH; Georgieff M
    Anesth Analg; 1996 Aug; 83(2):262-8. PubMed ID: 8694303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous hemofiltration and platelet function in critically ill patients.
    Boldt J; Menges T; Wollbrück M; Sonneborn S; Hempelmann G
    Crit Care Med; 1994 Jul; 22(7):1155-60. PubMed ID: 8026206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiopulmonary bypass priming using a high dose of a balanced hydroxyethyl starch versus an albumin-based priming strategy.
    Boldt J; Suttner S; Brosch C; Lehmann A; Röhm K; Mengistu A
    Anesth Analg; 2009 Dec; 109(6):1752-62. PubMed ID: 19923501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluid replacement with hydroxyethyl starch in critical care--a reassessment.
    Hartog CS; Welte T; Schlattmann P; Reinhart K
    Dtsch Arztebl Int; 2013 Jun; 110(26):443-50. PubMed ID: 23885279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the carrier solution for hydroxyethyl starch on platelet aggregation and clot formation.
    Schaden E; Wetzel L; Kozek-Langenecker S; Thaler U; Scharbert G
    Br J Anaesth; 2012 Oct; 109(4):572-7. PubMed ID: 22791802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Six percent hydroxyethyl starch 130/0.4 (Voluven®) versus 5% human serum albumin for volume replacement therapy during elective open-heart surgery in pediatric patients.
    Van der Linden P; De Villé A; Hofer A; Heschl M; Gombotz H
    Anesthesiology; 2013 Dec; 119(6):1296-309. PubMed ID: 23934169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective evaluation of the effects of administration of tetrastarch (hydroxyethyl starch 130/0.4) on plasma creatinine concentration in dogs (2010-2013): 201 dogs.
    Yozova ID; Howard J; Adamik KN
    J Vet Emerg Crit Care (San Antonio); 2016 Jul; 26(4):568-77. PubMed ID: 27144501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroxyethyl starch versus albumin in cardiopulmonary bypass prime solutions.
    Saunders CR; Carlisle L; Bick RL
    Ann Thorac Surg; 1983 Nov; 36(5):532-9. PubMed ID: 6195981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes of the hemostatic network in critically ill patients--is there a difference between sepsis, trauma, and neurosurgery patients?
    Boldt J; Papsdorf M; Rothe A; Kumle B; Piper S
    Crit Care Med; 2000 Feb; 28(2):445-50. PubMed ID: 10708181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of 6% Hydroxyethyl Starch 130/0.4 on Inflammatory Response and Pulmonary Function in Patients Having Cardiac Surgery: A Randomized Clinical Trial.
    Lee MJ; Tannenbaum C; Mao G; Jia Y; Leung S; Yilmaz HO; Ince I; Soltesz E; Duncan AE
    Anesth Analg; 2021 Oct; 133(4):906-914. PubMed ID: 34406128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxyethyl starch in sepsis.
    Haase NR
    Dan Med J; 2014 Jan; 61(1):B4764. PubMed ID: 24393593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.